144 related articles for article (PubMed ID: 4369976)
21. The effect of PGE1 on ADP-induced aggregation in refractory platelets.
Simard-Duquesne N; Dvornik D
Prostaglandins; 1973 Apr; 3(4):457-60. PubMed ID: 4354089
[No Abstract] [Full Text] [Related]
22. [Potentiation of the aggregating effect of ADP on rat platelets with the use of dextrans].
Stern E
Boll Soc Ital Biol Sper; 1974 Aug; 50(16-2):1269-72. PubMed ID: 4458713
[No Abstract] [Full Text] [Related]
23. Effects of dilazep on platelet aggregation.
Nakajima K; Shirai K; Takimoto M; Satoh F; Aoki M
Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1899-901. PubMed ID: 4480271
[No Abstract] [Full Text] [Related]
24. Role of cyclic AMP in platelet function.
Salzman EW; Weisenberger H
Adv Cyclic Nucleotide Res; 1972; 1():231-47. PubMed ID: 4353170
[No Abstract] [Full Text] [Related]
25. [Letter: Study of effects of 4 replacement solutions with a fluid gelatin base on platelet aggregation].
Marcel GA; Sabatier C; Galbrun M; Caspar C
Nouv Presse Med; 1974 Oct; 3(35):2260. PubMed ID: 4459835
[No Abstract] [Full Text] [Related]
26. [Platelet function and tests for their ascertainment].
David JL
Acta Clin Belg; 1975; 30(3):174-81. PubMed ID: 1231455
[No Abstract] [Full Text] [Related]
27. Inhibition of 5-hydroxytryptamine-induced human blood platelet aggregation by chlorpromazine and its metabolites.
Boullin DJ; Grahame-Smith DG; Grimes RP; Woods HF
Br J Pharmacol; 1975 Jan; 53(1):121-5. PubMed ID: 1125484
[TBL] [Abstract][Full Text] [Related]
28. Effect of ADP-induced shape change on incorporation of 32P into platelet phosphatidic acid and mono-, di- and triphosphatidyl inositol.
Lloyd JV; Nishizawa EE; Mustard JF
Br J Haematol; 1973 Jul; 25(1):77-99. PubMed ID: 4365702
[No Abstract] [Full Text] [Related]
29. Improved platelet economy using filler free silicone rubber in long term membrane lung perfusion.
Zapol WM; Bloom S; Carvalho A; Wonders T; Skoskiewicz M; Schneider R; Snider M
Trans Am Soc Artif Intern Organs; 1975; 21():587-92. PubMed ID: 167494
[No Abstract] [Full Text] [Related]
30. Inhibition of platelet aggregation and the platelet release reaction by alpha, omega diadenosine polyphosphates.
Harrison MJ; Brossmer R
FEBS Lett; 1975 Jun; 54(1):57-60. PubMed ID: 1132495
[No Abstract] [Full Text] [Related]
31. The effect of pyrimidine compounds on the potentiation of adenosine inhibition of aggregation, on adenosine phosphorylation and phosphodiesterase activity of blood platelets.
Rozenberg MC; Walker CM
Br J Haematol; 1973 Apr; 24(4):409-18. PubMed ID: 4351761
[No Abstract] [Full Text] [Related]
32. The influence of prostaglandins E1 and E2 on platelet aggregation in mammals.
Sinakos Z; Zamboulis C; Kartalis G; Koratzis J; Valtis D
Haematologica; 1974 Jun; 59(2):173-80. PubMed ID: 4216529
[No Abstract] [Full Text] [Related]
33. Effects of 6-[p-(4-phenylacetylpiperazin-1-yl)phenyl]-4,5-dihydro-3(2H)pyridazinone (CCI 17810) and aspirin on platelet aggregation and adhesiveness.
Griffett EM; Kinnon SM; Kumar A; Lecker D; Smith GM; Tomich EG
Br J Pharmacol; 1981 Apr; 72(4):697-705. PubMed ID: 7284687
[TBL] [Abstract][Full Text] [Related]
34. Effect of manganese on the ADP-induced platelet aggregation.
Fantin GP; Bottecchia D
Experientia; 1974 May; 30(5):555-6. PubMed ID: 4833692
[No Abstract] [Full Text] [Related]
35. Inhibition of platelet aggregation by isochinoline derivatives.
Markwardt F
Acta Univ Carol Med Monogr; 1972; 52():79-82. PubMed ID: 4361263
[No Abstract] [Full Text] [Related]
36. 6-methyl-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-2-one, a potent inhibitor of ADP-induced platelet aggregation.
Beverung WN; Partyka RA
J Med Chem; 1975 Feb; 18(2):224-5. PubMed ID: 1120996
[No Abstract] [Full Text] [Related]
37. Letter: Aggregation of human platelets by platelet-activating factor.
Benveniste J; Le Couedic JP; Kamoun P
Lancet; 1975 Feb; 1(7902):344-5. PubMed ID: 46496
[No Abstract] [Full Text] [Related]
38. Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses.
Evans RJ; Gordon JL
Br J Pharmacol; 1974 May; 51(1):123P. PubMed ID: 4441772
[No Abstract] [Full Text] [Related]
39. [Studies on inhibition of platelet aggregation by carbocromen (author's transl)].
Resag K; Melzer G; Nitz RE
Arzneimittelforschung; 1976 Feb; 26(2):209-13. PubMed ID: 947200
[TBL] [Abstract][Full Text] [Related]
40. 2,3-diphosphoglycerate: a physiological inhibitor of platelet aggregation.
Iatridis SG; Iatridis PG; Markidou SG; Ragatz BH
Science; 1975 Jan; 187(4173):259-61. PubMed ID: 1111100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
